title: Assessing the utility of the stop dialysate flow method in patients receiving haemodiafiltration.
abstract: BACKGROUND
  The stop dialysate flow (SDF) method of post-dialysis urea sampling is the most commonly used method in the UK. It can also be used with a published formula to predict 30 min equilibrated urea accurately. The method has not been validated in patients undergoing haemodiafiltration (HDF). Given the increased use of HDF across Europe, we felt it prudent to assess the utility of the SDF method and prediction equation in this modality.
  
  
  METHODS
  Fourteen patients from two renal units were studied. Blood samples were taken at 1 min intervals from the arterial side of the dialysis circuit in the first 5 min after HDF had ceased whilst blood circulation continued. A peripheral sample was taken from the contralateral arm immediately after HDF had ceased and a 30 min sample was taken from the arterial needle. These samples were used to assess the utility of 5 min arterial blood urea and the 30 min prediction formula, respectively.
  
  
  RESULTS
  Blood urea measured from the arterial circuit at 5 min correlated closely with the contralateral sample taken immediately post-HDF, with no significant difference (6.45+/-2.11 vs 6.52+/-2.19 mmol/l, P = 0.39). The use of 5 min arterial blood urea and prediction formula allowed an accurate prediction of 30 min urea (R2 = 0.96).
  
  
  CONCLUSIONS
  The use of the SDF method with a 5 min post-HDF arterial sample is valid in patients receiving HDF. The previously published prediction formula for estimating 30 min urea is also valid using the 5 min post-HDF sample.
authors.affiliation: Renal Unit, Western Infirmary, Glasgow, UK. jamie.traynor@northglasgow.scot.nhs.uk
authors.forename: J P
authors.initials: JP
authors.lastname: Traynor
authors.forename: H A
authors.initials: HA
authors.lastname: Oun
authors.forename: P
authors.initials: P
authors.lastname: McKenzie
authors.forename: I R
authors.initials: IR
authors.lastname: Shilliday
authors.forename: I G
authors.initials: IG
authors.lastname: McKay
authors.forename: A
authors.initials: A
authors.lastname: Dunlop
authors.forename: C C
authors.initials: CC
authors.lastname: Geddes
authors.forename: R A
authors.initials: RA
authors.lastname: Mactier
mesh_terms: D015415:Biomarkers / Q000097:blood; D015314:Dialysis Solutions / Q000008:administration & dosage*; D005260:Female; D005500:Follow-Up Studies; D017583:Hemodiafiltration / Q000379:methods*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D012680:Sensitivity and Specificity; D013048:Specimen Handling / Q000379:methods*; D014508:Urea / Q000097:blood*
chemical_list: D015415:Biomarkers; D015314:Dialysis Solutions; D014508:Urea